Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

NCT02191579 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

BIOLOGICAL: onabotulinumtoxinA
DRUG: Topiramate

Sponsor

Allergan